Roche Hldg Ltd https://investorshangout.com/Roche-Hldg-Ltd-RHHBY-66155/en-usSat, 12 Sep 2026 17:29:35 GMTCopyright InvestorsHangout.comwhytestocks: $RHHBY News Article - Late-Breaking Data for Genentech's BTK Inhibitor Fenebrutinib Show Brain Penethttps://investorshangout.com/post/view?id=6632291https://investorshangout.com/post/view?id=6632291Fri, 13 Oct 2023 20:51:12 GMTwhytestocks: $RHHBY News Article - Genentech Provides Update on Phase III SKYSCRAPER-01 Study in PD-L1-High Metashttps://investorshangout.com/post/view?id=6611331https://investorshangout.com/post/view?id=6611331Wed, 23 Aug 2023 14:25:51 GMTwhytestocks: $RHHBY News Article - Roche receives FDA clearance for additional Alzheimer's disease Cerebrospinal https://investorshangout.com/post/view?id=6590371https://investorshangout.com/post/view?id=6590371Tue, 27 Jun 2023 19:15:50 GMTwhytestocks: $RHHBY News Article - New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy https://investorshangout.com/post/view?id=6435920https://investorshangout.com/post/view?id=6435920Mon, 11 Jul 2022 15:45:52 GMTwhytestocks: $RHHBY News Article - Data at the 2022 ASCO Annual Meeting Highlight Genentech's Continued Commitmenhttps://investorshangout.com/post/view?id=6409154https://investorshangout.com/post/view?id=6409154Tue, 24 May 2022 14:50:51 GMTwhytestocks: $RHHBY News Article - Roche launches the first infectious disease tests and cobas omni Utility Channhttps://investorshangout.com/post/view?id=6302385https://investorshangout.com/post/view?id=6302385Wed, 15 Dec 2021 17:55:50 GMTwhytestocks: $RHHBY News Article - New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) as a Highly Effechttps://investorshangout.com/post/view?id=5891039https://investorshangout.com/post/view?id=5891039Fri, 11 Sep 2020 17:35:46 GMTwhytestocks: $RHHBY News Article - Genentech to Present New and Updated Data for Seven Approved and Investigationhttps://investorshangout.com/post/view?id=5595321https://investorshangout.com/post/view?id=5595321Mon, 18 Nov 2019 20:05:44 GMTGovind: The latest market intelligence report on the https://investorshangout.com/post/view?id=5542925https://investorshangout.com/post/view?id=5542925Thu, 19 Sep 2019 07:19:36 GMTwhytestocks: $RHHBY News Article - FDA Grants Priority Review to Genentech's Rituxan (Rituximab) in Children withhttps://investorshangout.com/post/view?id=5460034https://investorshangout.com/post/view?id=5460034Wed, 12 Jun 2019 17:50:41 GMTwhytestocks: $RHHBY News Article - European Commission approves Roche's Hemlibra for people with severe haemophilhttps://investorshangout.com/post/view?id=5379420https://investorshangout.com/post/view?id=5379420Thu, 14 Mar 2019 18:10:43 GMTdoobins: Buying ITMN for $74 / Share! Roche to Acquire InterMune for $74.00/Share in Cash The Dealhttps://investorshangout.com/post/view?id=1907920https://investorshangout.com/post/view?id=1907920Mon, 25 Aug 2014 03:42:39 GMTEmylers: RHHBY Financials 07/16/2014 10:06:03 Roche Holding Ltd Period Ending Dec 31, 2013 Dec 31, 2012 Dechttps://investorshangout.com/post/view?id=1666695https://investorshangout.com/post/view?id=1666695Wed, 16 Jul 2014 15:05:59 GMTStock_Tracker: Latest Roche Hldg Ltd Spons (RHHBY) Headlines Who Will Capture This $3.5 Billion Opportunity? Tohttps://investorshangout.com/post/view?id=1316873https://investorshangout.com/post/view?id=1316873Tue, 11 Mar 2014 08:51:17 GMTchartguy89: RHHBY 37.05 Stock Charts $RHHBY 1 Month Chart https://investorshangout.com/post/view?id=1306517https://investorshangout.com/post/view?id=1306517Sun, 09 Mar 2014 17:31:23 GMTchartguy89: RHHBY Stock Charts Last: -0.12 Saturday, March 1, 2014 at 9:18:19 AM $RHHBY 1 Mohttps://investorshangout.com/post/view?id=1268680https://investorshangout.com/post/view?id=1268680Sat, 01 Mar 2014 14:18:31 GMT